Search Ontology:
ChEBI
ritlecitinib
- Term ID
- CHEBI:229233
- Synonyms
-
- 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one
- PF 06651600
- PF-06651600
- PF06651600
- ritlecitinib
- ritlecitinibum
- Definition
- A pyrrolopyrimidine that is 7H-pyrrolo[2,3-d]pyrimidine substituted at position 4 by a [(3R,6S)-6-methyl-1-(prop-2-enoyl)piperidin-3-yl]amino group. It is a dual inhibitor of Janus kinase 3 and the TEC family of tyrosine kinases.
- References
-
- CAS:1792180-81-4
- DrugBank:DB14924
- PMID:31082193
- PMID:32419304
- PMID:33757798
- PMID:34826225
- PMID:35000236
- PMID:35210753
- PMID:35732501
- PMID:36623678
- PMID:36807251
- PMID:36808638
- PMID:36872080
- PMID:36977960
- PMID:37062298
- PMID:37403610
- PMID:37455588
- PMID:37521227
- PMID:37550228
- PMID:37556041
- PMID:37561322
- PMID:37691236
- PMID:37707764
- PMID:37777018
- PMID:37812490
- PMID:37917289
- PMID:38051245
- PMID:38051803
- PMID:38141256
- Wikipedia:Ritlecitinib
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse is_conjugate_acid_of
-
- is_conjugate_base_of
-
Phenotype
Phenotype resulting from ritlecitinib
Phenotype where environments contain ritlecitinib
Phenotype modified by environments containing ritlecitinib
Human Disease Model